Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| BT-20 | 0 | uM | 9 | 2500.00 | 1434.95 | 4610.00 | 4319.25 | 1.0673 | 1.0837 | |
| BT-20 | 17-AAG | 0.1 | uM | 9 | 2500.00 | 1434.95 | 1307.00 | 4319.25 | 0.3026 | -0.0571 |
| BT-20 | Erlotinib | 0.1 | uM | 9 | 2500.00 | 1434.95 | 4687.00 | 4319.25 | 1.0851 | 1.1055 |
| BT-20 | Lapatinib | 0.31623 | uM | 9 | 2500.00 | 1434.95 | 4461.00 | 4319.25 | 1.0328 | 1.0410 |
| BT-20 | Linsitinib | 0.31623 | uM | 9 | 2500.00 | 1434.95 | 4304.00 | 4319.25 | 0.9965 | 0.9956 |
| BT-20 | Lapatinib | 0.01 | uM | 9 | 2500.00 | 1434.95 | 4540.00 | 4319.25 | 1.0511 | 1.0637 |
| BT-20 | Linsitinib | 0.031623 | uM | 9 | 2500.00 | 1434.95 | 4374.00 | 4319.25 | 1.0127 | 1.0159 |
| BT-20 | Erlotinib | 0.031623 | uM | 9 | 2500.00 | 1434.95 | 4449.00 | 4319.25 | 1.0300 | 1.0376 |
| BT-20 | Erlotinib | 1 | uM | 9 | 2500.00 | 1434.95 | 3724.00 | 4319.25 | 0.8622 | 0.8219 |
| BT-20 | 17-AAG | 0.000302 | uM | 9 | 2500.00 | 1434.95 | 4246.00 | 4319.25 | 0.9830 | 0.9786 |
| BT-20 | Lapatinib | 3.1623 | uM | 9 | 2500.00 | 1434.95 | 3222.00 | 4319.25 | 0.7460 | 0.6633 |
| BT-20 | 17-AAG | 0.31623 | uM | 9 | 2500.00 | 1434.95 | 1063.00 | 4319.25 | 0.2461 | -0.1720 |
| BT-20 | 0 | uM | 9 | 2500.00 | 1434.95 | 4278.00 | 4319.25 | 0.9905 | 0.9880 | |
| BT-20 | 0 | uM | 9 | 2500.00 | 1434.95 | 3667.00 | 4319.25 | 0.8490 | 0.8043 | |
| BT-20 | Linsitinib | 1 | uM | 9 | 2500.00 | 1434.95 | 3752.00 | 4319.25 | 0.8687 | 0.8305 |
| BT-20 | Erlotinib | 0.31623 | uM | 9 | 2500.00 | 1434.95 | 3694.00 | 4319.25 | 0.8552 | 0.8126 |
| BT-20 | 0 | uM | 9 | 2500.00 | 1434.95 | 4465.00 | 4319.25 | 1.0337 | 1.0422 | |
| BT-20 | Linsitinib | 19.9526 | uM | 9 | 2500.00 | 1434.95 | 2135.00 | 4319.25 | 0.4943 | 0.2839 |
| BT-20 | Linsitinib | 0.0033113 | uM | 9 | 2500.00 | 1434.95 | 4364.00 | 4319.25 | 1.0104 | 1.0130 |
| BT-20 | Erlotinib | 10 | uM | 9 | 2500.00 | 1434.95 | 2783.00 | 4319.25 | 0.6443 | 0.5169 |
| BT-20 | Erlotinib | 3.1623 | uM | 9 | 2500.00 | 1434.95 | 3418.00 | 4319.25 | 0.7913 | 0.7262 |
| BT-20 | 17-AAG | 0.0031623 | uM | 9 | 2500.00 | 1434.95 | 4060.00 | 4319.25 | 0.9400 | 0.9236 |
| BT-20 | Erlotinib | 0.01 | uM | 9 | 2500.00 | 1434.95 | 4161.00 | 4319.25 | 0.9634 | 0.9536 |
| BT-20 | Linsitinib | 0.01 | uM | 9 | 2500.00 | 1434.95 | 4698.00 | 4319.25 | 1.0877 | 1.1086 |
| BT-20 | 17-AAG | 0.0001 | uM | 9 | 2500.00 | 1434.95 | 4656.00 | 4319.25 | 1.0780 | 1.0967 |